NASDAQ$BTTC

Black Titan Corp · Q2 2019 earnings

Q2 2019 earnings · Reported Aug 14, 2019 (7 years ago) · Investor relations

Aug 14Jun 30, 2019

Total Revenue

$11K

Previous: $605K-98.2%

EPS (adj)

-$228.00

Previous: -$144.00-58.3%

Capital Expenditures

$39K

Previous: -$5K+880.0%

Free Cash Flow

-$4.19M

Previous: -$1.85M-126.3%

Net Income

-$204K

Previous: $22.6K-1003.3%

Operating Income

-$186K

Previous: $38.5K-584.3%

Gross Profit

$11K

Previous: $397K-97.2%

Cash & Equivalents

$46.9K

Previous: $64.7K-27.4%

Total Assets

$2.74M

Previous: $4.14M-34.0%

Stock-Based Comp

$350K

Previous: $402K-12.9%

Titan Pharmaceuticals · Revenue · Quarterly

$11K

Q2 2019-98.2%vs Q2 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation